Adolescent and young adult oncology clinical practice guidelines in oncology Journal Article


Authors: Coccia, P. F.; Altman, J.; Bhatia, S.; Borinstein, S. C.; Flynn, J.; George, S.; Goldsby, R.; Hayashi, R.; Huang, M. S.; Johnson, R. H.; Beaupin, L. K.; Link, M. P.; Oeffinger, K. C.; Orr, K. M.; Pappo, A. S.; Reed, D.; Spraker, H. L.; Thomas, D. A.; von Mehren, M.; Wechsler, D. S.; Whelan, K. F.; Zebrack, B.; Sundar, H.; Shead, D. A.
Article Title: Adolescent and young adult oncology clinical practice guidelines in oncology
Abstract: Cancer is the leading cause of death among the adolescent and young adult (AYA) population, excluding homicide, suicide, or unintentional injury. AYA patients should be managed by a multidisciplinary team of health care professionals who are well-versed in the specific developmental issues relevant to this patient population. The recommendations for age-appropriate care outlined in these NCCN Guidelines include psychosocial assessment, a discussion of infertility risks associated with treatment and options for fertility preservation, genetic and familial risk assessment for all patients after diagnosis, screening and monitoring of late effects in AYA cancer survivors after successful completion of therapy, and palliative care and end-of-life considerations for patients for whom curative therapy fails. © JNCCN - Journal of the National Comprehensive Cancer Network.
Keywords: adolescent; adult; leukemia; young adult; acute granulocytic leukemia; gene mutation; busulfan; prednisone; paresthesia; review; cisplatin; doxorubicin; cancer risk; cancer radiotherapy; radiation dose; cytarabine; methotrexate; antineoplastic agent; cancer diagnosis; cancer incidence; sentinel lymph node biopsy; neoplasm; neoplasms; cancer palliative therapy; colorectal cancer; palliative care; gastrointestinal stromal tumor; paraganglioma; unindexed drug; melanoma; metastasis; lung toxicity; nephrotoxicity; bone marrow suppression; etoposide; heart disease; kidney disease; mucosa inflammation; thrombocytopenia; tinnitus; cohort analysis; risk factors; cancer screening; alkylating agent; cyclophosphamide; vincristine; cancer pain; kidney failure; practice guideline; hematopoietic stem cell transplantation; brca1 protein; brca2 protein; oncology; carmustine; ifosfamide; procarbazine; acute lymphoblastic leukemia; childhood cancer; gonad dysfunction; growth hormone deficiency; hodgkin disease; cancer survivor; risk assessment; dyspnea; ewing sarcoma; pneumonia; medicaid; tumor suppressor gene; cryopreservation; myelodysplastic syndrome; nonhodgkin lymphoma; whole body radiation; fluorescence in situ hybridization; cardiovascular risk; heart failure; heart infarction; colon cancer; mismatch repair; family history; breast carcinoma; lymphoma; clinical evaluation; acute myeloblastic leukemia; graft versus host reaction; neuropsychological test; patient compliance; bleomycin; cancer fatigue; health care personnel; psychosocial care; chromosomal instability; behavior; interpersonal communication; familial cancer; thyroid cancer; thyroid carcinoma; alternative medicine; physical activity; terminal care; high risk population; gonadorelin agonist; clear cell carcinoma; hypogonadism; urinalysis; hyperthyroidism; hypothyroidism; anthracycline derivative; rhabdomyosarcoma; immune deficiency; lifestyle modification; immunosuppressive treatment; pheochromocytoma; family relation; human relation; germ cell tumor; malignant peripheral nerve sheath tumor; emotionality; protein mlh1; protein msh6; congestive heart failure; hemorrhagic cystitis; early detection of cancer; hearing impairment; socioeconomics; environmental exposure; burkitt lymphoma; mismatch repair protein pms2; cowden syndrome; blood pressure measurement; chemoradiotherapy; immunosuppressive agent; uterine cervix carcinoma; cerebrovascular accident; cardiomyopathy; bladder disease; adenomatous polyp; raynaud phenomenon; female infertility; vagina carcinoma; peer group; male infertility; oligospermia; hair loss; succinate dehydrogenase; central nervous system disease; fertility preservation; adrenal insufficiency; carbon monoxide; pericardial disease; uterus disease; valvular heart disease; chronic cough; mantle field radiotherapy; ovarian reserve; anticipatory nausea and vomiting; medroxyprogesterone; gonad function; epipodophyllotoxin derivative; menorrhagia; premature ovarian failure; hand paresthesia; hearing test; asymptomatic disease; chemotherapy induced nausea and vomiting; amphotericin; aminoglycoside derivative; gonadotropin deficiency; ovariopexy; reproductive procedure; adolescent medicine
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 10
Issue: 9
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2012-09-01
Start Page: 1112
End Page: 1150
Language: English
PROVIDER: scopus
PUBMED: 22956810
DOI/URL:
Notes: --- - "Export Date: 2 November 2012" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Kevin Oeffinger
    296 Oeffinger